- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04043182
EFFECTIVENESS OF ULTRASOUND FOR LOCAL FAT TREATMENT (n)
August 1, 2019 updated by: São Paulo State University
ULTRASOUND FOR LOCAL FAT TREATMENT: A RANDOMIZED AND DOUBLE-BLIND CLINICAL TEST, CONTROLLED BY PLACEBO
It's evident that the literature shows good results on the use of aesthetic ultrasound in the treatment of localized fat, however, little has been explored so far, about possible psychological influences of this method and therefore, it is believed that it is pertinent to elaborate studies that include a placebo group, in order to measure the real effects from the exclusive application of ultrasound.
Therefore, the objective of this study will be to verify the influence of the application of aesthetic ultrasound in the treatment of localized fat, using for both clinical, biochemical and functional parameters.
Study Overview
Detailed Description
There will be included 30 participants, female gender, communities between 18 and 30 years, apparently Saudi, local abdominal fat, located in three groups: control (n = 10), experimental (n = 10) and placebo (n = 10) .
Or group control não recebeu nenhum type of intervention.
No experimental group, 10 sessões de ultrassom (Skinner brand, São Paulo) will be carried out in the previous region for 20 minutes.
No placebo group will be applied ultrassom (Skinner brand, São Paulo), pormem com zerada intensities.
Anthropometric avaliação e of dobras cutâneas will be carried out at this time before applying the treatment protocol.
As skin folds will be measured by means of adipometers.
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jaqueline Lopes, master
- Phone Number: 66999202206
- Email: jaqueee-santosss@hotmail.com
Study Contact Backup
- Name: Aryane Machado, PHD
- Phone Number: 16981251595
- Email: ary_machado@hotmail.com
Study Locations
-
-
Mount
-
Barra do Garças, Mount, Brazil, 78600-000
- Recruiting
- Jaqueline Lopes
-
Contact:
- Jaqueline Lopes
- Phone Number: 66999202206
- Email: jaqueee-santosss@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Additional inclusion criteria included body mass index (BMI) equal to or less than 25.0 kg / m2
- Adipose tissue thickness 2.6 cm or more in the treatment region;
- Preserved elasticity and local tissue integrity;
- In addition, participants had to agree not to change their daily routines during the study.
Exclusion Criteria:
- Pregnancy.
- Breastfeeding;
- History of liposuction;
- Lipolysis by injection therapy;
- Abdominoplasty or surgery in the treatment region;
- Weight reduction medication;
- Recent surgery in the last 12 months;
- Implantable electrical device;
- Neurosurgical deviation;
- Hernia;
- Sensory loss or dysesthesia in the treatment region;
- Cancer;
- Circulation problems;
- Or chronic systemic disease such as diabetes or metabolic syndrome.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: group control
You will not receive any type of intervention
|
|
Experimental: treatment group (ultrasound)
Will perform protocols of 10 sessions of ultrasound in the region of abdomen
|
The treatment protocol will consist of 10 sessions, lasting 20 minutes.
The energy level corresponding to 59 J / cm2 (177 J / cm2) and frequency of 3 MHZ, applied in the anterior region of the abdomen, in a quadrant previously delimited with a ballpoint pen, will be used.
The flanks (lateral of the abdomen) will not be treated.
|
Placebo Comparator: placebo group
It will perform protocols of 10 sessions of ultrasound in the region of abdomen, but the apparatus will be with zero intensities
|
The treatment protocol will consist of 10 sessions, lasting 20 minutes.
The energy level corresponding to 59 J / cm2 (177 J / cm2) and frequency of 3 MHZ, applied in the anterior region of the abdomen, in a quadrant previously delimited with a ballpoint pen, will be used.
The flanks (lateral of the abdomen) will not be treated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change abdominal circumference (centimeters-cm), before and after intervention
Time Frame: before (day 0) and post protocol (post 8 weeks)
|
To measure values corresponding to the waist / quadrile ratio, metric phyta will be used, which will collect measurements in centimeters (cm).
Assim, at waist circumference, it will be measured at umbigo height.
|
before (day 0) and post protocol (post 8 weeks)
|
change blood analysis (milligrams per decilitre-mg/dl ) before and after intervention
Time Frame: before (day 0) and post protocol (post 8 weeks)
|
A biochemical analysis will be carried out with the use of soro from blood collection in the antecubital vein, collected at a quantity of 10 mL as participants in the jejum study did not start and end the treatment as ultrassom.
As shown below, BIOPLUS 2000 semi-automatic biochemical method will be evaluated for a dosage of parameters such as Triglycerides, Total Cholesterol, High Density Lipoprotein - HDL and Baixa Densidade Lipoprotein Estimates - LDL and Baixíssima Densidade Lipoprotein - VLDL through calculation formula Friedewald As dosagens will be carried out not the Laboratory of Biochemistry of the University Center of Vale do Araguaia - UNIVAR).
|
before (day 0) and post protocol (post 8 weeks)
|
weight (centimeters-cm)
Time Frame: before (day 0)
|
stadiometer (Sanny, American Medical do Brasil, São Paulo, Brazil).
|
before (day 0)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
anthropometric characteristics anthropometric characteristics, photometry and personal satisfaction
Time Frame: before (day 0)
|
It will be measured by meio de uma meio de uma balança (Tanita BC554, Iron Man / Inner Scaner, Tanita, Illinois, United States) and a stadiometer (Sanny, American Medical do Brasil, São Paulo, Brazil).
In this way, the height will be measured in centimeters and the weight in kilograms.
|
before (day 0)
|
change photometry - reduction of waist measurements before and after intervention
Time Frame: before (day 0) and post protocol (post 8 weeks)
|
A photograph will be taken with a professional camera of Canon Brand Powershot Sx530 Hs, with a fixed focal length and constant lighting.
|
before (day 0) and post protocol (post 8 weeks)
|
personal satisfaction of the participants treated before and after intervention
Time Frame: before (day 0) and post protocol (post 8 weeks)
|
A satisfação pessoal will be measured by means of a questionnaire, the objective of which will be to investigate these variables in a subjective way.
Assim, the participants will be instructed to trace a 10 cm analog visual scale between two extremes, being 0 or "minimum possível" and 10 indicating "or more possível" for each classification.
The satisfaction scale ranges from zero to ten.
|
before (day 0) and post protocol (post 8 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 29, 2019
Primary Completion (Anticipated)
September 25, 2019
Study Completion (Anticipated)
September 30, 2019
Study Registration Dates
First Submitted
July 12, 2019
First Submitted That Met QC Criteria
August 1, 2019
First Posted (Actual)
August 2, 2019
Study Record Updates
Last Update Posted (Actual)
August 2, 2019
Last Update Submitted That Met QC Criteria
August 1, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- SaoPSU_univar
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fat Burn
-
BTL Industries Ltd.Active, not recruiting
-
BTL Industries Ltd.Completed
-
BTL Industries Ltd.CompletedFat BurnUnited States
-
BTL Industries Ltd.WithdrawnFat BurnUnited States, Bulgaria
-
BTL Industries Ltd.CompletedFat BurnUnited States
-
BTL Industries Ltd.Active, not recruitingFat BurnUnited States
-
BTL Industries Ltd.Completed
-
National Taiwan UniversityCompleted